Xu Liang, MD, Associate Professor
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China
Youth Committee Member, Breast group, China Anti-Cancer Association
Member of Professional Committee of Clinical Oncology, China medical Women’s Association
Youth Committee Member, Professional Committee of Internal Medicine, Beijing Breast Society
Dr. Liang graduated from the Peking University People’s Hospital in 2005, then she joined the Department of Breast Medicine, School of Clinical Oncology, Peking University until now, and had studied at Tokyo Cancer Center, Japan, in 2008. As a visiting Professor at the Institute Curie, France from 2016 to 2018. She has been engaged in the diagnosis and treatment of advanced breast cancer for a long time. The main research direction and focus are standardized treatment and individualized treatment of advanced breast cancer. As the investigator and sub-investigator, She has participated multiple international and domestic multicenter clinical trials focusing on advanced breast cancer and published more than ten papers in SCI and core journals in China.
Articles Published in the Annals of Translational Medicine